PortfoliosLab logoPortfoliosLab logo
TIL vs. PRCT
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

TIL vs. PRCT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Instil Bio, Inc. (TIL) and PROCEPT BioRobotics Corporation (PRCT). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

TIL vs. PRCT - Yearly Performance Comparison


2026 (YTD)20252024202320222021
TIL
Instil Bio, Inc.
-25.09%-42.38%150.52%-39.52%-96.32%-11.02%
PRCT
PROCEPT BioRobotics Corporation
-20.50%-60.93%92.13%0.89%66.09%-40.37%

Fundamentals

EPS

TIL:

-$11.24

PRCT:

-$2.58

Total Revenue (TTM)

TIL:

$0.00

PRCT:

$308.05M

Gross Profit (TTM)

TIL:

-$753.00K

PRCT:

$196.23M

EBITDA (TTM)

TIL:

-$66.93M

PRCT:

-$89.40M

Returns By Period

In the year-to-date period, TIL achieves a -25.09% return, which is significantly lower than PRCT's -20.50% return.


TIL

1D
3.39%
1M
-7.42%
YTD
-25.09%
6M
-53.86%
1Y
-52.53%
3Y*
-14.57%
5Y*
-55.53%
10Y*

PRCT

1D
-2.11%
1M
10.22%
YTD
-20.50%
6M
-29.92%
1Y
-57.07%
3Y*
-4.15%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Instil Bio, Inc.

PROCEPT BioRobotics Corporation

Return for Risk

TIL vs. PRCT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TIL
TIL Risk / Return Rank: 2626
Overall Rank
TIL Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
TIL Sortino Ratio Rank: 3232
Sortino Ratio Rank
TIL Omega Ratio Rank: 3232
Omega Ratio Rank
TIL Calmar Ratio Rank: 1919
Calmar Ratio Rank
TIL Martin Ratio Rank: 2323
Martin Ratio Rank

PRCT
PRCT Risk / Return Rank: 77
Overall Rank
PRCT Sharpe Ratio Rank: 55
Sharpe Ratio Rank
PRCT Sortino Ratio Rank: 55
Sortino Ratio Rank
PRCT Omega Ratio Rank: 77
Omega Ratio Rank
PRCT Calmar Ratio Rank: 88
Calmar Ratio Rank
PRCT Martin Ratio Rank: 1212
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TIL vs. PRCT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Instil Bio, Inc. (TIL) and PROCEPT BioRobotics Corporation (PRCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TILPRCTDifference

Sharpe ratio

Return per unit of total volatility

-0.42

-0.97

+0.56

Sortino ratio

Return per unit of downside risk

0.10

-1.61

+1.71

Omega ratio

Gain probability vs. loss probability

1.01

0.82

+0.19

Calmar ratio

Return relative to maximum drawdown

-0.66

-0.90

+0.23

Martin ratio

Return relative to average drawdown

-1.01

-1.42

+0.41

TIL vs. PRCT - Sharpe Ratio Comparison

The current TIL Sharpe Ratio is -0.42, which is higher than the PRCT Sharpe Ratio of -0.97. The chart below compares the historical Sharpe Ratios of TIL and PRCT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


TILPRCTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.42

-0.97

+0.56

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.51

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.52

-0.17

-0.35

Correlation

The correlation between TIL and PRCT is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

TIL vs. PRCT - Dividend Comparison

Neither TIL nor PRCT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

TIL vs. PRCT - Drawdown Comparison

The maximum TIL drawdown since its inception was -98.83%, which is greater than PRCT's maximum drawdown of -77.18%. Use the drawdown chart below to compare losses from any high point for TIL and PRCT.


Loading graphics...

Drawdown Indicators


TILPRCTDifference

Max Drawdown

Largest peak-to-trough decline

-98.83%

-77.18%

-21.65%

Max Drawdown (1Y)

Largest decline over 1 year

-82.27%

-65.12%

-17.15%

Max Drawdown (5Y)

Largest decline over 5 years

-98.72%

Current Drawdown

Current decline from peak

-98.48%

-74.85%

-23.63%

Average Drawdown

Average peak-to-trough decline

-82.01%

-30.01%

-52.00%

Ulcer Index

Depth and duration of drawdowns from previous peaks

53.64%

40.98%

+12.66%

Volatility

TIL vs. PRCT - Volatility Comparison

The current volatility for Instil Bio, Inc. (TIL) is 14.93%, while PROCEPT BioRobotics Corporation (PRCT) has a volatility of 21.09%. This indicates that TIL experiences smaller price fluctuations and is considered to be less risky than PRCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


TILPRCTDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.93%

21.09%

-6.16%

Volatility (6M)

Calculated over the trailing 6-month period

78.00%

44.70%

+33.30%

Volatility (1Y)

Calculated over the trailing 1-year period

126.42%

58.84%

+67.58%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

108.52%

64.84%

+43.68%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

108.43%

64.84%

+43.59%

Financials

TIL vs. PRCT - Financials Comparison

This section allows you to compare key financial metrics between Instil Bio, Inc. and PROCEPT BioRobotics Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
76.38M
(TIL) Total Revenue
(PRCT) Total Revenue
Values in USD except per share items